Thioguanine: Essential Guide To Uses, Dosing, Side Effects

What is thioguanine?

Thioguanine, also spelled

tioguanine

or known as

6-thioguanine (6-TG)

, belongs to a class of medications called

antimetabolites

. These drugs interfere with DNA and RNA synthesis by mimicking natural purine bases, thereby inhibiting cell proliferation, particularly in rapidly dividing cells like those in cancers or hyperproliferative skin conditions. In New Zealand, thioguanine is officially registered for treating certain cancers, primarily

acute leukaemias

such as acute myelogenous leukaemia (AML) and acute lymphoblastic leukaemia (ALL). Off-label, it has gained recognition for managing

moderate to severe psoriasis

, especially in cases recalcitrant to other therapies.

Unlike related thiopurines like

azathioprine

and

6-mercaptopurine (6-MP)

, thioguanine bypasses certain metabolic pathways that produce toxic metabolites such as methyl-thioinosine monophosphate (MeTIMP), potentially reducing adverse effects. This makes it a valuable option for patients intolerant to conventional thiopurines. Clinical evidence supports its efficacy in inflammatory bowel disease (IBD) and psoriasis, with low-dose regimens showing high drug survival rates.

Who uses thioguanine?

Thioguanine is prescribed to:

• Patients with

  acute leukaemias

  (registered indication in New Zealand).
• Individuals with

  moderate to severe psoriasis

  unresponsive to first-line treatments like topical therapies, phototherapy, or methotrexate (off-label use).
• In some cases, patients with

  inflammatory bowel disease (IBD)

  , including Crohn’s disease and ulcerative colitis, particularly those intolerant to azathioprine or 6-MP.
• Occasionally for other autoimmune or proliferative disorders under specialist supervision.

Clinical trials demonstrate that over

70% of psoriasis patients

experience improvement with thioguanine, either via daily or pulse dosing. In IBD, low-dose thioguanine shows superior

drug survival

compared to other thiopurines, with 86% of patients continuing treatment at 60 months versus 42% on 6-MP.

How does thioguanine work?

Thioguanine acts as a

purine analogue

. Once metabolized intracellularly into

6-thioguanine nucleotides (6-TGN)

, it is incorporated into DNA and RNA, disrupting nucleic acid synthesis and inducing apoptosis in susceptible cells. In psoriasis, it targets hyperproliferative keratinocytes; in leukaemia, it affects malignant haematopoietic cells.

Key metabolic advantages include:

• Direct conversion to active 6-TGN without intermediate steps prone to toxicity (e.g., no MeTIMP accumulation).
• Potentially faster onset and better tolerability than azathioprine or 6-MP.

In psoriasis treatment, mechanisms may also involve immunomodulation, reducing T-cell activation and cytokine production.

Dosing regimens for thioguanine

For

psoriasis

(off-label):

• Daily dosing: Start at

  20 mg daily

  for 4 weeks, increasing by 20 mg increments to

  80-120 mg daily

  until response.
• Pulse dosing: Preferred to minimize toxicity;

  80 mg twice weekly

  , increasing by 20 mg every 2-4 weeks to max

  160 mg three times weekly

  .

For

IBD

(low-dose): 20 mg once or every second day (half of 40 mg tablets).

For

leukaemia

: Higher doses per oncology protocols, often 60-100 mg/m² daily.

Condition	Regimen	Max Dose	Notes
Psoriasis (Daily)	20 mg/day, titrate up	120 mg/day	Monitor blood weekly
Psoriasis (Pulse)	80 mg 2x/week, titrate	160 mg 3x/week	Reduces marrow toxicity
IBD	20 mg daily or EOD	Low-dose	High survival rate

Monitoring for thioguanine

Strict monitoring is essential due to

bone marrow suppression

risk.

• Blood counts: Full blood count (FBC) every

  2-4 weeks

  before and during therapy. Watch for anaemia, leucopenia, thrombocytopenia.
• Liver function tests (LFTs): Baseline and regular; monitor for jaundice, hepatomegaly.
• 6-TGN levels: Median 364 pmol/8×10^8 RBCs in IBD patients.
• Mean corpuscular volume (MCV): Lower with thioguanine vs. other thiopurines.
• Uric acid: Monitor for hyperuricaemia; use allopurinol if needed.

Stop immediately at first sign of abnormality; effects may be delayed.

Side effects of thioguanine

The primary dose-limiting effect is

bone marrow toxicity

:

• Anaemia (low haemoglobin)
• Leucopenia (low WBCs, infection risk)
• Thrombocytopenia (low platelets, bleeding risk)

Other effects:

• Hepatotoxicity: Jaundice, elevated LFTs, nodular regenerative hyperplasia.
• Hyperuricaemia: Gout, renal stones; prevent with hydration, allopurinol.
• Gastrointestinal: Nausea, vomiting (less common than other thiopurines).
• Infections: Due to immunosuppression.
• Rash, alopecia: Rare.

In psoriasis studies, pulse dosing reduces toxicity incidence. In IBD, thioguanine shows fewer discontinuations.

Precautions when taking thioguanine

• Avoid if pregnant/breastfeeding (teratogenic).
• Vaccinations: Live vaccines contraindicated.
• Infection/bleeding risk: Report fever, bruising, sore throat immediately.
• Drug interactions: Allopurinol increases toxicity; dose adjust.
• Sun protection: Increased skin cancer risk with long-term use.
• Alcohol: Limit to avoid liver strain.

Benefits of thioguanine in psoriasis

In recalcitrant psoriasis, thioguanine achieves significant clearing:

• >70% improvement in trials.
• Pulse regimens effective and safer than daily.
• Alternative for methotrexate-intolerant patients.

In IBD: Longer survival, similar efficacy to thiopurines.

Alternatives to thioguanine

Drug/Class	Use	Pros	Cons
Methotrexate	Psoriasis	Well-established	Liver toxicity
Azathioprine/6-MP	Psoriasis/IBD	Oral	More side effects
Biologics (e.g., TNF inhibitors)	Psoriasis/IBD	Targeted	Costly, IV
Cyclosporine	Psoriasis	Rapid	Renal toxicity

Frequently Asked Questions

What is thioguanine used for?

Primarily acute leukaemias; off-label for severe psoriasis and IBD.

Is thioguanine safe for long-term use?

With monitoring, yes, but risks include marrow suppression. Pulse dosing improves safety.

How soon does thioguanine work for psoriasis?

Response in weeks to months; titrate dose gradually.

Can thioguanine cause cancer?

Long-term immunosuppression raises skin cancer risk; regular checks needed.

What if I miss a dose?

Take as soon as remembered unless near next dose; consult doctor.